. Archives of Disease in Childhood, 48, 229. Terbutaline in children with asthma. A double-blind, single-dose trial was carried out on 30 asthmatic children to study the effect of oral terbutaline in two different concentrations and of a placebo on ventilatory function and pulse rate. The higher dose of terbutaline (0 075 mg/kg) gave a satisfactory and prolonged action on ventilation without cardiovascular side effects.
of the broncholytic effect and cardiovascular side effects of terbutaline, given as a single dose and in different concentrations, in asthmatic children.
Materials and methods Patients. 10 girls and 20 boys ranging in age from 5 to 13, all suffering from moderately severe or severe bronchial asthma with symptoms from 4 to 11 years, were studied. All were in hospital because of the severity of the disease.
To be accepted into the trial a patient's peak expiratory flow rate, measured each moming of the trial, was 70% or less of the predicted normal value based on age, sex, and height (Dugdale and Moeri, 1968; Godfrey, Kamburoff, and Nairn, 1970) .
At the time of the trial 4 children were receiving steroids and 3 disodium cromoglycate. All bronchodilator drugs and disodium cromoglycate were stopped 12 hours before the trial was carried out. Children receiving steroids or antibiotics continued this treatment throughout the trial period in unchanged doses. The trial was carried out as a double-blind study on three consecutive days, a single dose of placebo and two different doses of terbutaline being given orally on separate days. One dose of terbutaline corresponded to the adult dose (0 075 mg/kg), the other dose being half this (0 0375 mg/kg). Terbutaline (Mainland, 1963; Snedecor and Cochran, 1967) was used for evaluation of the results, the degree of significance being given as significant (P <0 01), or highly significant (P <0 001).
Results
Airway obstruction. The lower dose of terbutaline had a significant effect after 1 hour, and a highly significant effect after 2 and 3 hours (Table I, Fig. 1 ). The effect after the higher dose was highly significant after the first 3 hours, and significant after 5 hours (Table I, Fig. 1.) The difference in effect between the high dose of terbutaline and placebo was highly significant after the first 3 hours, and significant after 5 hours. Between the lower dose and placebo the difference was highly significant after 3 hours. Between the two doses of terbutaline the difference was significant after 1 and 2 hours (Table I) . Pulse rate. The rise in pulse rate was almost Side effects. No side effects were noted at any significant after 2 hours using the high dose of time during or after the trial. terbutaline. Otherwise there were no changes in pulse rate at any time using any of the solutions Discussion (Table II, Fig. 2) .
The results show that orally administered terbutaline in the concentrations used produces 8-marked bronchodilatation in asthmatic children TT for a period of at least 5 hours without tachycardia.
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